Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain

Psychosomatics

Volumn 46, Issue 5, 2005, Pages 379-384

  Krell, Heather V ^a   Leuchter, Andrew F ^a   Cook, Ian A ^a   Abrams, Michelle ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CYCLOBENZAPRINE; FLUOXETINE; LEVOTHYROXINE; MAPROTILINE; PAROXETINE; PLACEBO; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; ADRENERGIC RECEPTOR AFFECTING AGENT; MORPHOLINE DERIVATIVE;

CLINICAL PRACTICE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; DEPRESSION; DIARRHEA; DRUG EFFICACY; DRUG MECHANISM; FIBROMYALGIA; HUMAN; HYPOTENSION; LOW BACK PAIN; META ANALYSIS; NAUSEA; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW; XEROSTOMIA; ADULT; CASE REPORT; CHRONIC DISEASE; FEMALE; MALE; MIDDLE AGED;

ADRENERGIC UPTAKE INHIBITORS; ADULT; ANTIDEPRESSIVE AGENTS; CHRONIC DISEASE; FEMALE; FIBROMYALGIA; HUMANS; LOW BACK PAIN; MALE; MIDDLE AGED; MORPHOLINES;

EID: 32944463053     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.46.5.379     Document Type: Review

References (54)

1. Sawynok J, Esser MJ, Reid AR: Antidepressants as analgesics: an overview of central and peripheral mechanisms of action. J Psychiatry Neurosci 2001; 26:21-29
2. Gallagher RM, Verma S: Managing pain and comorbid depression: a public health challenge. Semin Clin Neuropsychiatry 1999; 4:203-220
3. Basbum AI, Fields HL: Endogenous pain control mechanism: review and hypothesis. Ann Neurol 1978; 4:451-462
4. Atkinson JH, Slater MA, Williams RA, Zisook S, Patterson TL, Grant I, Wahlgren DR, Abramson I, Garfin SR: A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain. Pain 1998; 76:287-296
5. Arnold LM, Keck PE Jr, Welge JA: Antidepressant treatment of fibromyalgia: a meta-analysis and review. Psychosomatics 2000; 41:104-113
6. Arnold LM, Hess EV, Hudson JI, Welge JA, Berno SE, Keck PE Jr: A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 2002; 112:191-197
7. Moreland LW, St Clair EW: Pain management in the rheumatic diseases: the use of analgesics in pain rheumatic diseases. Rheum Dis Clin North Am 1999; 25:1-40
8. Devereaux MW: Low back pain. Prim Care 2004; 31:33-51
9. Jenkins DG, Ebbutt AF, Evans CD: Tofranil in the treatment of low back pain. J Int Med Res 1976; 4:28-40
10. Alcoff J, Jones E, Rust P, Newman R: Controlled trial of imipramine for chronic low back pain. J Fam Pract 1982; 14:841-846
11. Hameroff SR, Cork RC, Scherer K, Crago BR, Neuman C, Womble JR, Davis TP: Doxepin effects on chronic pain, depression and plasma opioids. J Clin Psychiatry 1982; 43:22-27
12. Pheasant H, Bursk A, Goldfarb J, Azen SP, Weiss JN, Borelli L: Amitriptyline and chronic low-back pain: a randomized double-blind crossover study. Spine 1983; 8:552-557
13. Ward N, Bokan JA, Phillips M, Benedetti C, Butler S, Spengler D: Antidepressants in concomitant chronic back pain and depression: doxepin and desipramine compared. J Clin Psychiatry 1984; 45:54-59
14. Hameroff SR, Weiss JL, Lerman JC, Cork RC, Watts KS, Crago BR, Neuman CP, Womble JR, Davis TP: Doxepin's effect on chronic pain and depression: a controlled study. J Clin Psychiatry 1984; 45:47-53
15. Goodkin K, Gullion CM, Agras WS: A randomized, double-blind, placebo-controlled trial of trazodone hydrochloride in chronic low back pain syndrome. J Clin Psychopharmacol 1990; 10:269-278
16. Treves R, Montaine de la Roque P, Dumond JJ, Bertin P, Arnaud M, Desproges-Gotteron R: Prospective study of the analgesic action of clomipramine versus placebo in refractory lumbosciatica (68 cases) (French). Rev Rhum Mal Osteoartic 1991; 58:549-552
17. Atkinson JH, Slater MA, Wahlgren DR, Williams RA, Zisook S, Pruitt SD, Epping-Jordan JE, Patterson TL, Grant I, Abramson I, Garfin SR: Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity. Pain 1999; 83:137-145
18. Storch H, Steck P: Concomitant thymoleptic therapy in the frame of a controlled study with maprotiline in the treatment of back pain (German). Nervenarzt 1982; 53:445-550
19. Goodkin K, Gullion CM, Agras WS: A randomized, double-blind, placebo-controlled trial of trazodone hydrochloride in chronic low back pain syndrome. J Clin Psychopharmacol 1990; 10:269-278
20. Carette S, McCain GA, Bell DA, Fam AG: Evaluation of amitriptyline in primary fibrositis: a double-blind, placebo-controlled study. Arthritis Rheum 1986; 29:655-659
21. Goldenberg DL, Felson DT, Dinerman H: A randomized controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 1986; 29:1371-1377
22. Gruber AJ, Hudson JI, Pope HG: The management of treatment-resistant depression in pain disorders on the interface of psychiatry and medicine. Psychiatr Clin North Am 1996; 19:351-369
23. Scudds RA, McCain GA, Rollman GB, Harth M: Improvements in pain responsiveness in patients with fibrositis after successful treatment with amitriptyline. J Rheumatol Suppl 1989; 19:98-103
24. Jaeschke R, Adachi J, Guyatt G, Keller J, Wong B: Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials. J Rheumatol 1991; 18:447-451
25. Kempenaers C, Simenon G, Vander Elst M, Fransolet L, Mingard P, de Maertelaer V, Appelboom T, Mendlewicz J: Effect of an antidiencephalon immune serum on pain and sleep in primary fibromyalgia. Neuropsychobiology 1994; 30:66-72
26. Carette S, Bell MJ, Reynolds WJ, Haraoui B, McCain GA, Bykerk VP, Edworthy SM, Baron M, Koehler BE, Fam AG, et al: Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia: a randomized, double-blind clinical trial. Arthritis Rheum 1994; 37:32-40
27. Ginsberg F, Mancaux A, Joos E, et al: A randomized placebo-controlled trial of sustained-release amitriptyline in primary fibromyalgia. J Musculo Pain 1996; 14:37-47
28. Goldenberg D, Mayskiy M, Mossley C, Ruthazer R, Schmid C: A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996; 39:1852-1859
29. Hannonen P, Malminiemi K, Yli-Kerttula U, Isomeri R, Roponen P: A randomized, double blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder. Br J Rheumatol 1998; 37: 1279-1286
30. Heymann RE, Helfenstein M, Feldman D: A double-blind, randomized, controlled study of amitriptyline, nortriptyline and placebo in patients with fibromyalgia. Clin Exp Rheumatol 2001; 9:697-702
31. Bibolotti E, Borani C, Tuscuili E, et al: The management of fibrositis: a double blind comparison of maprolamine, chlomipramine and placebo. Clin Trials J 1986; 23:269-280
32. Caruso I, Sarzi-Puttini PC, Boccassini L, Santandrea S, Locati M, Volpato R, Montrone F, Benvenuti C, Beretta A: Double-blind study of dothiepin versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res 1987; 15:154-159
33. Wolfe F, Cathey MA, Hawley DJ: Double blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheum 1994; 23:255-259
34. Norregaard J, Volkmann H, Danneskiold-Samsoe B: A randomized controlled trial of citalopram in the treatment of fibromyalgia. Pain 1995; 61:445-449
35. Branco JC: The diagnosis and treatment of fibromyalgia. Acta Med Port 1995; 8:233-238
36. Bennett RM, Gatter RA, Campbell SM, Andrews RP, Clark SR, Scarola JA: A comparison of cyclobenzaprine and placebo in the management of fibrositis: a double-blind controlled study. Arthritis Rheum 1988; 31:1535-1542
37. Quimby LG, Gratwick GM, Whitney CD, Block SR: A randomized trial of cyclobenzaprine for the treatment of fibromyalgia. J Rheumatol Suppl 1989; 19:140-143
38. Reynolds WJ, Moldofsky H, Saskin P, Lue FA: The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia. J Rheumatol 1991; 18:452-154
39. Santandrea S, Montone F, Sarzi-Puttini P, Boccassini L, Caruso I: A double-blind crossover study of two cyclobenzaprine regimens in primary fibromyalgia syndrome. J Int Med Res 1993; 21:74-80
40. Dwight MM, Arnold LM, O'Brien H, Metzger R, Morris-Park E, Keck PE Jr: An open clinical trial of venlafaxine treatment of fibromyalgia. Psychosomatics 1998; 39:14-17
41. Shaver JL: Fibromyalgia syndrome in women. Nurs Clin North Am 2004; 39:195-204
42. Moldofsky H: Management of sleep disorders in fibromyalgia. Rheum Dis Clin North Am 2002; 228:353-365
43. Sicutein F: Headache as a possible expression of brain deficiency of 5-hydroxytrptimine. Psychosomatic Med 1972; 12:69-72
44. Hudson JI, Hudson MS, Pliner LF, Goldenberg DL, Pope HG Jr: Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry 1985; 142:441-446
45. Rojas-Corrales MO, Casa J, Moreno-Brea MR, Gibert-Rahola J, Mico JA: Antinociceptive effects of tricyclic antidepressants and their noradrenergic metabolites. Fur Neuropsychopharmacol 2003; 13:355-363
46. Schatzberg AF: Clinical efficacy of reboxetine in major depression. J Clin Psychiatry 2000; 61:31-38
47. Krell H, Cook IA, Abrams M, et al: Reboxetine yields symptomatic and functional improvement in unipolar depression. Poster abstracts from the 41st Annual Meeting of the National Institutes of Mental Health's New Clinical Drug Evaluation Unit, May 27, 2001, Scottsdale, Ariz, poster Session II, number 26
48. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al: The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33:160-172
49. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Association, 1994, pp 213-233
50. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
51. Ware JE, Sherbourne CD: The MOS 36-item Short Form Health Survey (SF-36). Med Care 1992; 30:473-483
52. Fishbain D: Evidence-based data on pain relief with antidepressants. Ann Med 2000; 32:305-316
53. Ansari A: The efficacy of newer antidepressants in the treatment of chronic pain: a review of current literature. Harv Rev Psychiatry 2000; 7:257-263
54. Gruber AJ, Hudson JI, Pope HG: The management of treatment-resistant depression in pain disorders on the interface of psychiatry and medicine. Psychiatr Clin North Am 1996; 19:351-369